EventsThe 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S6. Novel and Sustainable approaches in Medicinal Chemistry of the event The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
29 Oct, 2025
Academic Editor
author-avatarM. Matilde Marques
Citation
Hugo F. Costa-Almeida, Xavier C. Correia, Beatriz L. Pires-Lima, Ivo E. Sampaio-Dias, Rational Design and Synthesis of Melanostatin Derivatives to Probe Structural and Functional Diversity , in Proceedings of The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Rational Design and Synthesis of Melanostatin Derivatives to Probe Structural and Functional Diversity

1. LAQV/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, Rua do Campo Alegre s/n, 4169-007 Porto, Portugal., Portugal
Abstract

N-Hydroxypeptides have recently attracted attention for their distinct conformational and physicochemical properties, which markedly influence biological activity. However, incorporating N-hydroxyproline into peptide sequences is synthetically demanding, typically requiring complex transformations with several protection/deprotection steps that reduce efficiency and sustainability of the synthesis process. In this study, we present an innovative strategy for the N-hydroxylation of proline in peptides using an on-site oxidation strategy via Cope elimination under mild conditions. The methodology is showcased through the assembly of an N-hydroxylated derivative of melanostatin neuropeptide.

Our approach demonstrates that the N-(cyanoethyl) group serves as a protecting moiety during peptide synthesis and as a leaving group in the oxidation step. Using N-(cyanoethyl)-L-proline as the starting material, peptide coupling with H-L-Leu-Gly-OMe afforded a melanostatin intermediate that, upon treatment with m-chloroperbenzoic acid, underwent an efficient Cope elimination to introduce the N-hydroxy group at the proline residue.

This single-step oxidation under mild conditions delivered the desired tripeptide with excellent yield (93%), avoiding additional deprotection steps. Comparative experiments revealed that incorporating the N-(cyanoethyl) group earlier in the synthesis significantly improved the global yield (78%) relative to late-stage derivatization (41%).

Overall, this work presents a novel strategy for the selective modification of prolyl-containing peptides, exemplified by the assembly of N-hydroxy-melanostatin. This on-site oxidation methodology, based on Cope elimination, offers a valuable tool for the development of bioactive N-hydroxylated peptides.

Keywords
Neurodegenerative diseases
Neuropeptides
N-Hydroxypeptides
Melanostatin
Poster
HugoAlmeida_ID.pdf
Evaluation of Curcumin and Its Derivatives as Photosensitizers for Antibacterial Photodynamic Therapy through an In-House Irradiation Assay
Evaluating the window of opportunity for intranasal insulin therapy in a rat model of cerebral ischemia